DE2553101A1 - Arzneimittel mit hypolipaemischer wirkung - Google Patents

Arzneimittel mit hypolipaemischer wirkung

Info

Publication number
DE2553101A1
DE2553101A1 DE19752553101 DE2553101A DE2553101A1 DE 2553101 A1 DE2553101 A1 DE 2553101A1 DE 19752553101 DE19752553101 DE 19752553101 DE 2553101 A DE2553101 A DE 2553101A DE 2553101 A1 DE2553101 A1 DE 2553101A1
Authority
DE
Germany
Prior art keywords
active ingredient
liver
thenoyl
acid
hyperlipemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19752553101
Other languages
German (de)
English (en)
Inventor
Nicholas William Ditullio
Charles Patrick Lowman
Alfred Roland Maass
Harry Link Saunders
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of DE2553101A1 publication Critical patent/DE2553101A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE19752553101 1974-11-27 1975-11-26 Arzneimittel mit hypolipaemischer wirkung Withdrawn DE2553101A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/527,560 US3969508A (en) 1974-11-27 1974-11-27 Lowering the concentration of plasma triglycerides

Publications (1)

Publication Number Publication Date
DE2553101A1 true DE2553101A1 (de) 1976-08-12

Family

ID=24101958

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752553101 Withdrawn DE2553101A1 (de) 1974-11-27 1975-11-26 Arzneimittel mit hypolipaemischer wirkung

Country Status (10)

Country Link
US (1) US3969508A (US07223432-20070529-C00017.png)
AU (1) AU499316B2 (US07223432-20070529-C00017.png)
BE (1) BE835823A (US07223432-20070529-C00017.png)
DE (1) DE2553101A1 (US07223432-20070529-C00017.png)
FR (1) FR2292470A1 (US07223432-20070529-C00017.png)
GB (1) GB1535203A (US07223432-20070529-C00017.png)
IL (1) IL48518A (US07223432-20070529-C00017.png)
NL (1) NL7513877A (US07223432-20070529-C00017.png)
PH (2) PH11295A (US07223432-20070529-C00017.png)
ZA (1) ZA757439B (US07223432-20070529-C00017.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1569404A (en) * 1977-04-22 1980-06-11 Soc D Etudes Prod Chimique (2-isopropyl-4-(2'-theonyl)-5-methyl) phenoxy acetic acid
US4089970A (en) * 1977-09-07 1978-05-16 Smithkline Corporation Method of inhibiting platelet aggregation
US4532135A (en) * 1981-02-09 1985-07-30 Edwards K David G Renoprotective treatments employing vasodilator compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB760114A (en) * 1953-06-19 1956-10-31 Chimie Atomistique Improvements in and relating to compositions for lowering the cholesterol level in the blood serum
US3402198A (en) * 1965-10-20 1968-09-17 William A. Bolhofer 2-(phenoxy), 2-(phenylthio) and 2-(anilino) substituted 2-alkylideneacetic acid derivatives
GB1228236A (US07223432-20070529-C00017.png) * 1968-05-20 1971-04-15
BE757001A (fr) * 1969-10-10 1971-03-16 Cerpha Derives heterocycliques d'acides phenoxy acetique et leur preparation

Also Published As

Publication number Publication date
NL7513877A (nl) 1976-05-31
FR2292470A1 (fr) 1976-06-25
PH12855A (en) 1979-09-12
ZA757439B (en) 1976-11-24
PH11295A (en) 1977-11-02
IL48518A0 (en) 1976-01-30
AU499316B2 (en) 1979-04-12
GB1535203A (en) 1978-12-13
BE835823A (fr) 1976-05-21
US3969508A (en) 1976-07-13
IL48518A (en) 1978-08-31
FR2292470B1 (US07223432-20070529-C00017.png) 1978-11-10
AU8689475A (en) 1977-06-02

Similar Documents

Publication Publication Date Title
DE69117922T2 (de) Zusammensetzungen gegen malaria
EP0128482B1 (de) Neue galenische Zubereitungsformen von oralen Antidiabetika und Verfahren zu ihrer Herstellung
DE3636123C2 (US07223432-20070529-C00017.png)
EP0128483B1 (de) Neue galenische Zubereitungsformen von oralen Antidiabetika und Verfahren zu ihrer Herstellung
DE3709621A1 (de) Therapeutisches mittel
CH649921A5 (de) Festes cerebralwirksames mittel.
DE3212736A1 (de) Verwendung von dihydropyridinen in arzneimitteln mit salidiuretischer wirkung
EP0317855B1 (de) Pharmazeutische Präparate
EP0205865B1 (de) Pharmazeutische Präparate mit antihypertensiver und kardioprotektiver Wirkung
DE2625222B2 (de) 13-Dithiacyclopentan-2-ylidenmalonsäureester, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2625012A1 (de) Arzneimittel zur heilung von leberkrankheiten
DE2553101A1 (de) Arzneimittel mit hypolipaemischer wirkung
DE69023045T2 (de) Carboxamidderivate.
DE2625220C3 (de) Arzneimittel zur Behandlung von Leberkrankheiten
DE1900772C3 (de) Salz aus N,N-Dimethylbiguanid und p-Chlorphenoxyessigsäure sowie dieses enthaltende Arzneimittel
DE1964504C3 (de) Arzneimittel zur Behandlung ödematöser Zustände und Hypertensionen
DE3530780C2 (de) Neue pharmazeutische Verwendung von 5-(3-n-Butyloxalylaminophenyl)-tetrazol
DE2705002A1 (de) Therapeutische zubereitung
DE2755017C2 (US07223432-20070529-C00017.png)
DE3904795C2 (de) Pharmazeutisches Präparat und dessen Verwendung
DE2708327A1 (de) Entzuendungshemmendes mittel
DE2625053B2 (de) Arzneimittel zur Kontrolle von Leberkrankheiten
EP0576452B1 (de) Erzeugnisse, enthaltend verapamil und trandolapril
EP0308665B1 (de) Salze der 5-Aminosalicylsäure und sie enthaltende Arzneimittelzubereitungen
DE3141970A1 (de) Arzneimittel zur behandlung der durch den virus der herpes-gruppe erzeugten erkrankungen

Legal Events

Date Code Title Description
8141 Disposal/no request for examination